selected publications
-
academic article
-
A randomized placebo-controlled phase II study of clarithromycin or placebo combined with VCD induction therapy prior to high-dose melphalan with stem cell support in patients with newly diagnosed multiple myeloma.
Experimental Hematology & Oncology.
7.
2018
Early relapsed disease of multiple myeloma following up-front HDM-ASCT: a study based on the Danish Multiple Myeloma Registry in the period 2005 to 2014.
Leukemia.
32.
2018
Lenalidomide versus lenalidomide + dexamethasone prolonged treatment after second‐line lenalidomide + dexamethasone induction in multiple myeloma.
Cancer Medicine.
7.
2018
Causes of early death in multiple myeloma patients treated with high‐dose therapy followed by autologous stem cell transplantation: A study based on the nationwide Danish Multiple Myeloma Registry.
American Journal of Hematology.
92.
2017
Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population.
PLoS ONE.
12.
2017
The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population‐based study.
Cancer Medicine.
6.
2017
134P APO010 sensitivity in relapsed multiple myeloma patients.
Annals of Oncology.
27.
2016
Smoldering multiple myeloma risk factors for progression: a Danish population‐based cohort study.
European Journal Of Haematology.
97.
2016
The Danish National Multiple Myeloma Registry.
Clinical Epidemiology.
Volume 8.
2016
Continued improvement in overall survival in elderly multiple myeloma patients after 2008; a population based study from the Danish Multiple Myeloma Registry.
Clinical Lymphoma Myeloma & Leukemia.
15.
2015
The Rev II Trial: Lenalidomide and Dexamethasone As Second Line Treatment in Myeloma Followed By Extended Lenalidomid Vs Len/Dex.
Blood.
126.
2015
-
dataset
-
Baseline characteristics for the entire cohort..
public-library-of-science.
2017
Immunoparesis and association to OS and PFS in different age groups..
public-library-of-science.
2017
Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population.
public-library-of-science.
2017
Multivariable analysis of both qualitative and quantitative immunoparesis as risk factors for OS and PFS in all patients..
public-library-of-science.
2017
Multivariable analysis of factors for OS..
public-library-of-science.
2017
Multivariable analysis of factors for PFS..
public-library-of-science.
2017